Jennifer Boer

Dr. Jennifer Boer is a Postdoctoral Research Fellow at RMIT University's Research & Innovation Capability department in Bundoora West, Australia. Her research focuses on immunology, clinical sciences, oncology, nanotechnology, and medical health sciences, with a particular emphasis on vaccine development, nanomedicine, and infectious disease mechanisms. She is actively involved in supervising Masters and PhD students, including projects like 'Metagenetic Approach to Analyse Vaccine Immunomodulation in the Elderly' and 'Gold-based drugs for the effective treatment of ovarian cancer'.

Her work spans interdisciplinary areas, such as vaccine delivery systems using liposomes and polymeric nanoparticles, and the study of SARS-CoV-2 mutations affecting protein flexibility. She also explores ethical and statistical aspects of animal experimentation design. Dr. Boer collaborates widely, contributing to fields like environmental microbiology, drug discovery pedagogy, and glaucoma immunotherapy.

Her recent publications highlight advancements in vaccine adjuvants, anaerobic sewage sludge analysis, and the role of tumor necrosis factor receptors in disease. She is open to mentoring students in these and related areas.